PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1453996
PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1453996
Injectable Cytotoxic Drugs Market Forecasts to 2030 - Global Analysis By Drug Type, Distribution Channel, Application, and By Geography
According to Stratistics MRC, the Global Injectable Cytotoxic Drugs Market is accounted for $18.9 billion in 2023 and is expected to reach $31.1 billion by 2030 growing at a CAGR of 7.4% during the forecast period. Injectable cytotoxic drugs refer to medications administered via injection to treat various cancers by targeting and destroying rapidly dividing cancer cells. These drugs work by interfering with cell division processes, inducing cell death, or inhibiting tumor growth. Often used in chemotherapy regimens, they include agents like methotrexate, doxorubicin, and vincristine. Despite their side effects, injectable cytotoxic drugs are crucial in cancer treatment, often used alone or in combination with other therapies to shrink tumors, prevent metastasis, and improve patients' overall survival rates.
Market Dynamics:
Driver:
Increasing healthcare expenditure
As healthcare budgets expand, there's greater accessibility to advanced cancer treatments, including cytotoxic drugs administered via injection. This increased spending enables healthcare systems to procure and offer a wider range of treatment options to patients diagnosed with cancer. Moreover, healthcare facilities are better equipped to handle the storage, administration, and management of injectable cytotoxic drugs, further facilitating their use in cancer treatment regimens and propelling this market further.
Restraint:
High development costs
Developing a new cytotoxic drug involves extensive preclinical studies, clinical trials, and regulatory approvals, which incur significant expenses at each stage of the process and contribute to substantial financial burdens for pharmaceutical companies. Moreover, navigating regulatory requirements and obtaining approvals from regulatory agencies such as the FDA in the United States and the EMA in Europe adds to the development costs, thereby gradually impedes this market growth.
Opportunity:
Advancements in drug development
Advancements in drug formulation technologies have led to the development of more stable, bioavailable cytotoxic drug formulations that improve drug delivery and tissue penetration. These advancements encompass various aspects of drug discovery, formulation, and delivery, contributing to the development of safer, more efficacious cytotoxic therapies. Moreover, these approaches enable researchers to identify compounds with enhanced selectivity and potency against cancer cells while minimizing off-target effects, propelling this market further.
Threat:
Side effects and toxicity
These medications, while effective in targeting rapidly dividing cancer cells, often lead to adverse effects that impact patients' quality of life and treatment adherence. Common side effects of injectable cytotoxic drugs include nausea, vomiting, hair loss, fatigue, and immunosuppression. Moreover, patients may also develop long-term complications from cytotoxic drug exposure, including secondary cancers and organ damage, which hinder this market size.
Covid-19 Impact
The COVID-19 pandemic has had several negative impacts on the injectable cytotoxic drug market. Disruptions in healthcare systems worldwide have led to delays in cancer screenings, diagnoses, and treatments, resulting in a reduction in the number of patients. Furthermore, logistical challenges arising from lockdowns, travel restrictions, and supply chain disruptions have hampered the production, distribution, and delivery of injectable cytotoxic drugs. This has further impacted patient access to injectable cytotoxic drugs, particularly in resource-limited settings, which significantly hinders this market.
The vinca alkaloids segment is expected to be the largest during the forecast period
The vinca alkaloids segment is estimated to hold the largest share, due to its pivotal role in cancer treatment. These drugs work by disrupting microtubule formation, thereby inhibiting cell division and inducing apoptosis in rapidly dividing cancer cells. Additionally, ongoing research and development efforts aim at optimizing Vinca alkaloids' therapeutic benefits while minimizing adverse effects, thereby boosting this segment's expansion.
The multiple sclerosis segment is expected to have the highest CAGR during the forecast period
The multiple sclerosis segment is anticipated to have highest CAGR during the forecast period due to its significant growth and innovation. Interferon beta-1a and interferon beta-1b drugs help regulate the immune system's response, reducing inflammation and the frequency of relapses in MS patients. Moreover, emerging therapies, including monoclonal antibodies targeting specific immune pathways, are expanding treatment options for MS patients, which is driving this segment's growth.
Region with largest share:
North America commanded the largest market share during the extrapolated period, owing to the high prevalence of cancer and autoimmune diseases such as multiple sclerosis, there is a substantial demand for injectable cytotoxic drugs across the region. The region benefits from a well-established healthcare infrastructure, advanced medical facilities, and a high level of healthcare spending. Furthermore, favorable reimbursement policies and insurance coverage contribute to patients' access to these essential medications, propelling this region's expansion.
Region with highest CAGR:
Europe is expected to witness highest CAGR over the projection period, owing to the region's strong pharmaceutical industry, cutting-edge research, and robust healthcare infrastructure. Collaborative efforts between academia, industry, and regulatory agencies in Europe foster innovation and accelerate the translation of research findings into clinical practice. In addition, Europe has witnessed the adoption of novel drug delivery technologies, enhancing the therapeutic efficacy and safety profile of injectable cytotoxic drugs, which drives this region further.
Key players in the market
Some of the key players in the Injectable Cytotoxic Drugs Market include Merck & Co. Inc., Pfizer, Inc., F. Hoffmann-La Roche Ltd., Amgen, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Sanofi, Johnson and Johnson Services Inc. , Abbie Inc, Novartis AG.
Key Developments:
In February 2024, Novartis announced that it has entered into an agreement to make a voluntary public takeover offer to acquire MorphoSys AG, a Germany-based, global biopharmaceutical company developing innovative medicines in oncology.
In July 2023, DTx Pharma, a preclinical stage biotechnology company addressing the delivery challenges of oligonucleotide therapeutics with its Fatty Acid Ligand Conjugated OligoNucleotide platform, announced that it has been acquired by Novartis.
Drug Types Covered:
- Vinca Alkaloids
- Anthracyclines
- Alkylating Agents
- Taxanes
- Antimetabolites
- Platinum Compounds
- Other Drug Types
Distribution Channel Covered:
- Retail Pharmacies
- Online Pharmacies
- Hospital Pharmacies
- Specialty Cancer Centers
- Other Distribution Channels
Applications Covered:
- Oncology
- Multiple Sclerosis
- Rheumatoid Arthritis
- Other Applications
Regions Covered:
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
- South America
- Argentina
- Brazil
- Chile
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
- Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
- Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
- Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
- 2.1 Abstract
- 2.2 Stake Holders
- 2.3 Research Scope
- 2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
- 2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions
3 Market Trend Analysis
- 3.1 Introduction
- 3.2 Drivers
- 3.3 Restraints
- 3.4 Opportunities
- 3.5 Threats
- 3.6 Application Analysis
- 3.7 Emerging Markets
- 3.8 Impact of Covid-19
4 Porters Five Force Analysis
- 4.1 Bargaining power of suppliers
- 4.2 Bargaining power of buyers
- 4.3 Threat of substitutes
- 4.4 Threat of new entrants
- 4.5 Competitive rivalry
5 Global Injectable Cytotoxic Drugs Market, By Drug Type
- 5.1 Introduction
- 5.2 Vinca Alkaloids
- 5.3 Anthracyclines
- 5.4 Alkylating Agents
- 5.5 Taxanes
- 5.6 Antimetabolites
- 5.7 Platinum Compounds
- 5.8 Other Drug Types
6 Global Injectable Cytotoxic Drugs Market, By Distribution Channel
- 6.1 Introduction
- 6.2 Retail Pharmacies
- 6.3 Online Pharmacies
- 6.4 Hospital Pharmacies
- 6.5 Specialty Cancer Centers
- 6.6 Other Distribution Channels
7 Global Injectable Cytotoxic Drugs Market, By Application
- 7.1 Introduction
- 7.2 Oncology
- 7.3 Multiple Sclerosis
- 7.4 Rheumatoid Arthritis
- 7.5 Other Applications
8 Global Injectable Cytotoxic Drugs Market, By Geography
- 8.1 Introduction
- 8.2 North America
- 8.2.1 US
- 8.2.2 Canada
- 8.2.3 Mexico
- 8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 Italy
- 8.3.4 France
- 8.3.5 Spain
- 8.3.6 Rest of Europe
- 8.4 Asia Pacific
- 8.4.1 Japan
- 8.4.2 China
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 New Zealand
- 8.4.6 South Korea
- 8.4.7 Rest of Asia Pacific
- 8.5 South America
- 8.5.1 Argentina
- 8.5.2 Brazil
- 8.5.3 Chile
- 8.5.4 Rest of South America
- 8.6 Middle East & Africa
- 8.6.1 Saudi Arabia
- 8.6.2 UAE
- 8.6.3 Qatar
- 8.6.4 South Africa
- 8.6.5 Rest of Middle East & Africa
9 Key Developments
- 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
- 9.2 Acquisitions & Mergers
- 9.3 New Product Launch
- 9.4 Expansions
- 9.5 Other Key Strategies
10 Company Profiling
- 10.1 Merck & Co. Inc.
- 10.2 Pfizer, Inc.
- 10.3 F. Hoffmann-La Roche Ltd.
- 10.4 Amgen, Inc.
- 10.5 Bristol-Myers Squibb Company
- 10.6 Eli Lilly and Company
- 10.7 Sanofi
- 10.8 Johnson and Johnson Services Inc.
- 10.9 Abbie Inc
- 10.10 Novartis AG
List of Tables
- Table 1 Global Injectable Cytotoxic Drugs Market Outlook, By Region (2021-2030) ($MN)
- Table 2 Global Injectable Cytotoxic Drugs Market Outlook, By Drug Type (2021-2030) ($MN)
- Table 3 Global Injectable Cytotoxic Drugs Market Outlook, By Vinca Alkaloids (2021-2030) ($MN)
- Table 4 Global Injectable Cytotoxic Drugs Market Outlook, By Anthracyclines (2021-2030) ($MN)
- Table 5 Global Injectable Cytotoxic Drugs Market Outlook, By Alkylating Agents (2021-2030) ($MN)
- Table 6 Global Injectable Cytotoxic Drugs Market Outlook, By Taxanes (2021-2030) ($MN)
- Table 7 Global Injectable Cytotoxic Drugs Market Outlook, By Antimetabolites (2021-2030) ($MN)
- Table 8 Global Injectable Cytotoxic Drugs Market Outlook, By Platinum Compounds (2021-2030) ($MN)
- Table 9 Global Injectable Cytotoxic Drugs Market Outlook, By Other Drug Types (2021-2030) ($MN)
- Table 10 Global Injectable Cytotoxic Drugs Market Outlook, By Distribution Channel (2021-2030) ($MN)
- Table 11 Global Injectable Cytotoxic Drugs Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
- Table 12 Global Injectable Cytotoxic Drugs Market Outlook, By Online Pharmacies (2021-2030) ($MN)
- Table 13 Global Injectable Cytotoxic Drugs Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
- Table 14 Global Injectable Cytotoxic Drugs Market Outlook, By Specialty Cancer Centers (2021-2030) ($MN)
- Table 15 Global Injectable Cytotoxic Drugs Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
- Table 16 Global Injectable Cytotoxic Drugs Market Outlook, By Application (2021-2030) ($MN)
- Table 17 Global Injectable Cytotoxic Drugs Market Outlook, By Oncology (2021-2030) ($MN)
- Table 18 Global Injectable Cytotoxic Drugs Market Outlook, By Multiple Sclerosis (2021-2030) ($MN)
- Table 19 Global Injectable Cytotoxic Drugs Market Outlook, By Rheumatoid Arthritis (2021-2030) ($MN)
- Table 20 Global Injectable Cytotoxic Drugs Market Outlook, By Other Applications (2021-2030) ($MN)
- Table 21 North America Injectable Cytotoxic Drugs Market Outlook, By Country (2021-2030) ($MN)
- Table 22 North America Injectable Cytotoxic Drugs Market Outlook, By Drug Type (2021-2030) ($MN)
- Table 23 North America Injectable Cytotoxic Drugs Market Outlook, By Vinca Alkaloids (2021-2030) ($MN)
- Table 24 North America Injectable Cytotoxic Drugs Market Outlook, By Anthracyclines (2021-2030) ($MN)
- Table 25 North America Injectable Cytotoxic Drugs Market Outlook, By Alkylating Agents (2021-2030) ($MN)
- Table 26 North America Injectable Cytotoxic Drugs Market Outlook, By Taxanes (2021-2030) ($MN)
- Table 27 North America Injectable Cytotoxic Drugs Market Outlook, By Antimetabolites (2021-2030) ($MN)
- Table 28 North America Injectable Cytotoxic Drugs Market Outlook, By Platinum Compounds (2021-2030) ($MN)
- Table 29 North America Injectable Cytotoxic Drugs Market Outlook, By Other Drug Types (2021-2030) ($MN)
- Table 30 North America Injectable Cytotoxic Drugs Market Outlook, By Distribution Channel (2021-2030) ($MN)
- Table 31 North America Injectable Cytotoxic Drugs Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
- Table 32 North America Injectable Cytotoxic Drugs Market Outlook, By Online Pharmacies (2021-2030) ($MN)
- Table 33 North America Injectable Cytotoxic Drugs Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
- Table 34 North America Injectable Cytotoxic Drugs Market Outlook, By Specialty Cancer Centers (2021-2030) ($MN)
- Table 35 North America Injectable Cytotoxic Drugs Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
- Table 36 North America Injectable Cytotoxic Drugs Market Outlook, By Application (2021-2030) ($MN)
- Table 37 North America Injectable Cytotoxic Drugs Market Outlook, By Oncology (2021-2030) ($MN)
- Table 38 North America Injectable Cytotoxic Drugs Market Outlook, By Multiple Sclerosis (2021-2030) ($MN)
- Table 39 North America Injectable Cytotoxic Drugs Market Outlook, By Rheumatoid Arthritis (2021-2030) ($MN)
- Table 40 North America Injectable Cytotoxic Drugs Market Outlook, By Other Applications (2021-2030) ($MN)
- Table 41 Europe Injectable Cytotoxic Drugs Market Outlook, By Country (2021-2030) ($MN)
- Table 42 Europe Injectable Cytotoxic Drugs Market Outlook, By Drug Type (2021-2030) ($MN)
- Table 43 Europe Injectable Cytotoxic Drugs Market Outlook, By Vinca Alkaloids (2021-2030) ($MN)
- Table 44 Europe Injectable Cytotoxic Drugs Market Outlook, By Anthracyclines (2021-2030) ($MN)
- Table 45 Europe Injectable Cytotoxic Drugs Market Outlook, By Alkylating Agents (2021-2030) ($MN)
- Table 46 Europe Injectable Cytotoxic Drugs Market Outlook, By Taxanes (2021-2030) ($MN)
- Table 47 Europe Injectable Cytotoxic Drugs Market Outlook, By Antimetabolites (2021-2030) ($MN)
- Table 48 Europe Injectable Cytotoxic Drugs Market Outlook, By Platinum Compounds (2021-2030) ($MN)
- Table 49 Europe Injectable Cytotoxic Drugs Market Outlook, By Other Drug Types (2021-2030) ($MN)
- Table 50 Europe Injectable Cytotoxic Drugs Market Outlook, By Distribution Channel (2021-2030) ($MN)
- Table 51 Europe Injectable Cytotoxic Drugs Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
- Table 52 Europe Injectable Cytotoxic Drugs Market Outlook, By Online Pharmacies (2021-2030) ($MN)
- Table 53 Europe Injectable Cytotoxic Drugs Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
- Table 54 Europe Injectable Cytotoxic Drugs Market Outlook, By Specialty Cancer Centers (2021-2030) ($MN)
- Table 55 Europe Injectable Cytotoxic Drugs Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
- Table 56 Europe Injectable Cytotoxic Drugs Market Outlook, By Application (2021-2030) ($MN)
- Table 57 Europe Injectable Cytotoxic Drugs Market Outlook, By Oncology (2021-2030) ($MN)
- Table 58 Europe Injectable Cytotoxic Drugs Market Outlook, By Multiple Sclerosis (2021-2030) ($MN)
- Table 59 Europe Injectable Cytotoxic Drugs Market Outlook, By Rheumatoid Arthritis (2021-2030) ($MN)
- Table 60 Europe Injectable Cytotoxic Drugs Market Outlook, By Other Applications (2021-2030) ($MN)
- Table 61 Asia Pacific Injectable Cytotoxic Drugs Market Outlook, By Country (2021-2030) ($MN)
- Table 62 Asia Pacific Injectable Cytotoxic Drugs Market Outlook, By Drug Type (2021-2030) ($MN)
- Table 63 Asia Pacific Injectable Cytotoxic Drugs Market Outlook, By Vinca Alkaloids (2021-2030) ($MN)
- Table 64 Asia Pacific Injectable Cytotoxic Drugs Market Outlook, By Anthracyclines (2021-2030) ($MN)
- Table 65 Asia Pacific Injectable Cytotoxic Drugs Market Outlook, By Alkylating Agents (2021-2030) ($MN)
- Table 66 Asia Pacific Injectable Cytotoxic Drugs Market Outlook, By Taxanes (2021-2030) ($MN)
- Table 67 Asia Pacific Injectable Cytotoxic Drugs Market Outlook, By Antimetabolites (2021-2030) ($MN)
- Table 68 Asia Pacific Injectable Cytotoxic Drugs Market Outlook, By Platinum Compounds (2021-2030) ($MN)
- Table 69 Asia Pacific Injectable Cytotoxic Drugs Market Outlook, By Other Drug Types (2021-2030) ($MN)
- Table 70 Asia Pacific Injectable Cytotoxic Drugs Market Outlook, By Distribution Channel (2021-2030) ($MN)
- Table 71 Asia Pacific Injectable Cytotoxic Drugs Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
- Table 72 Asia Pacific Injectable Cytotoxic Drugs Market Outlook, By Online Pharmacies (2021-2030) ($MN)
- Table 73 Asia Pacific Injectable Cytotoxic Drugs Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
- Table 74 Asia Pacific Injectable Cytotoxic Drugs Market Outlook, By Specialty Cancer Centers (2021-2030) ($MN)
- Table 75 Asia Pacific Injectable Cytotoxic Drugs Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
- Table 76 Asia Pacific Injectable Cytotoxic Drugs Market Outlook, By Application (2021-2030) ($MN)
- Table 77 Asia Pacific Injectable Cytotoxic Drugs Market Outlook, By Oncology (2021-2030) ($MN)
- Table 78 Asia Pacific Injectable Cytotoxic Drugs Market Outlook, By Multiple Sclerosis (2021-2030) ($MN)
- Table 79 Asia Pacific Injectable Cytotoxic Drugs Market Outlook, By Rheumatoid Arthritis (2021-2030) ($MN)
- Table 80 Asia Pacific Injectable Cytotoxic Drugs Market Outlook, By Other Applications (2021-2030) ($MN)
- Table 81 South America Injectable Cytotoxic Drugs Market Outlook, By Country (2021-2030) ($MN)
- Table 82 South America Injectable Cytotoxic Drugs Market Outlook, By Drug Type (2021-2030) ($MN)
- Table 83 South America Injectable Cytotoxic Drugs Market Outlook, By Vinca Alkaloids (2021-2030) ($MN)
- Table 84 South America Injectable Cytotoxic Drugs Market Outlook, By Anthracyclines (2021-2030) ($MN)
- Table 85 South America Injectable Cytotoxic Drugs Market Outlook, By Alkylating Agents (2021-2030) ($MN)
- Table 86 South America Injectable Cytotoxic Drugs Market Outlook, By Taxanes (2021-2030) ($MN)
- Table 87 South America Injectable Cytotoxic Drugs Market Outlook, By Antimetabolites (2021-2030) ($MN)
- Table 88 South America Injectable Cytotoxic Drugs Market Outlook, By Platinum Compounds (2021-2030) ($MN)
- Table 89 South America Injectable Cytotoxic Drugs Market Outlook, By Other Drug Types (2021-2030) ($MN)
- Table 90 South America Injectable Cytotoxic Drugs Market Outlook, By Distribution Channel (2021-2030) ($MN)
- Table 91 South America Injectable Cytotoxic Drugs Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
- Table 92 South America Injectable Cytotoxic Drugs Market Outlook, By Online Pharmacies (2021-2030) ($MN)
- Table 93 South America Injectable Cytotoxic Drugs Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
- Table 94 South America Injectable Cytotoxic Drugs Market Outlook, By Specialty Cancer Centers (2021-2030) ($MN)
- Table 95 South America Injectable Cytotoxic Drugs Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
- Table 96 South America Injectable Cytotoxic Drugs Market Outlook, By Application (2021-2030) ($MN)
- Table 97 South America Injectable Cytotoxic Drugs Market Outlook, By Oncology (2021-2030) ($MN)
- Table 98 South America Injectable Cytotoxic Drugs Market Outlook, By Multiple Sclerosis (2021-2030) ($MN)
- Table 99 South America Injectable Cytotoxic Drugs Market Outlook, By Rheumatoid Arthritis (2021-2030) ($MN)
- Table 100 South America Injectable Cytotoxic Drugs Market Outlook, By Other Applications (2021-2030) ($MN)
- Table 101 Middle East & Africa Injectable Cytotoxic Drugs Market Outlook, By Country (2021-2030) ($MN)
- Table 102 Middle East & Africa Injectable Cytotoxic Drugs Market Outlook, By Drug Type (2021-2030) ($MN)
- Table 103 Middle East & Africa Injectable Cytotoxic Drugs Market Outlook, By Vinca Alkaloids (2021-2030) ($MN)
- Table 104 Middle East & Africa Injectable Cytotoxic Drugs Market Outlook, By Anthracyclines (2021-2030) ($MN)
- Table 105 Middle East & Africa Injectable Cytotoxic Drugs Market Outlook, By Alkylating Agents (2021-2030) ($MN)
- Table 106 Middle East & Africa Injectable Cytotoxic Drugs Market Outlook, By Taxanes (2021-2030) ($MN)
- Table 107 Middle East & Africa Injectable Cytotoxic Drugs Market Outlook, By Antimetabolites (2021-2030) ($MN)
- Table 108 Middle East & Africa Injectable Cytotoxic Drugs Market Outlook, By Platinum Compounds (2021-2030) ($MN)
- Table 109 Middle East & Africa Injectable Cytotoxic Drugs Market Outlook, By Other Drug Types (2021-2030) ($MN)
- Table 110 Middle East & Africa Injectable Cytotoxic Drugs Market Outlook, By Distribution Channel (2021-2030) ($MN)
- Table 111 Middle East & Africa Injectable Cytotoxic Drugs Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
- Table 112 Middle East & Africa Injectable Cytotoxic Drugs Market Outlook, By Online Pharmacies (2021-2030) ($MN)
- Table 113 Middle East & Africa Injectable Cytotoxic Drugs Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
- Table 114 Middle East & Africa Injectable Cytotoxic Drugs Market Outlook, By Specialty Cancer Centers (2021-2030) ($MN)
- Table 115 Middle East & Africa Injectable Cytotoxic Drugs Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
- Table 116 Middle East & Africa Injectable Cytotoxic Drugs Market Outlook, By Application (2021-2030) ($MN)
- Table 117 Middle East & Africa Injectable Cytotoxic Drugs Market Outlook, By Oncology (2021-2030) ($MN)
- Table 118 Middle East & Africa Injectable Cytotoxic Drugs Market Outlook, By Multiple Sclerosis (2021-2030) ($MN)
- Table 119 Middle East & Africa Injectable Cytotoxic Drugs Market Outlook, By Rheumatoid Arthritis (2021-2030) ($MN)
- Table 120 Middle East & Africa Injectable Cytotoxic Drugs Market Outlook, By Other Applications (2021-2030) ($MN)
